Galena Biopharma to Present at the 2012 Aegis Capital Healthcare Conference
LAKE OSWEGO, Ore., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and CEO, will present a corporate overview at the 2012 Aegis Capital Healthcare Conference. The presentation will take place on Friday, September 28, 2012 at 12:45 p.m. PDT at The Wynn in Las Vegas, NV.
About Galena Biopharma
Galena Biopharma, Inc. is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com .
The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647
CONTACT: Madeline Hatton Toll free: +1 (855) 855-GALE (4253), ext. 109 firstname.lastname@example.org or Remy Bernarda IR Sense, LLC +1 (415) 203-6386 email@example.com
Source: Galena Biopharma 2012 GlobeNewswire, Inc.